Total Payments
$1,539
2024 Payments
$291.50
Companies
23
Transactions
80
Medicare Patients
2,373
Medicare Billing
$230,784
Payment Breakdown by Category
Food & Beverage$1,509 (98.0%)
Education$30.06 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,509 | 79 | 98.0% |
| Education | $30.06 | 1 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $888.47 | 46 | $0 (2024) |
| PFIZER INC. | $120.97 | 8 | $0 (2021) |
| Neuronetics, Inc. | $67.63 | 1 | $0 (2022) |
| Philips Electronics North America Corporation | $43.58 | 2 | $0 (2021) |
| Abbott Laboratories | $40.43 | 1 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $35.98 | 2 | $0 (2019) |
| Amgen Inc. | $33.83 | 2 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $32.82 | 2 | $0 (2020) |
| Medtronic Vascular, Inc. | $31.28 | 2 | $0 (2019) |
| Upsher-Smith Laboratories LLC | $25.64 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $291.50 | 13 | ABBVIE INC. ($246.60) |
| 2023 | $101.51 | 5 | ABBVIE INC. ($83.22) |
| 2022 | $428.17 | 21 | ABBVIE INC. ($237.68) |
| 2021 | $409.20 | 23 | AbbVie Inc. ($320.97) |
| 2020 | $56.81 | 3 | Upsher-Smith Laboratories LLC ($25.64) |
| 2019 | $77.69 | 5 | Medtronic Vascular, Inc. ($31.28) |
| 2018 | $103.76 | 5 | PFIZER INC. ($44.61) |
| 2017 | $70.10 | 5 | PFIZER INC. ($37.20) |
All Payment Transactions
80 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.39 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: VACCINES | ||||||
| 08/01/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: NEUROSCIENCE | ||||||
| 07/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Biological | ||||||
| 06/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: NEUROSCIENCE | ||||||
| 01/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: NEUROSCIENCE | ||||||
| 12/08/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Inflammation | ||||||
| 11/22/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Inflammation | ||||||
| 11/21/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $40.43 | General |
| Category: Neuromodulation | ||||||
| 11/18/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $7.49 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.47 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2022 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $67.63 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 330 | 416 | $93,712 | $32,761 |
| 2022 | 15 | 827 | 1,080 | $233,624 | $80,376 |
| 2021 | 12 | 738 | 1,048 | $214,698 | $78,161 |
| 2020 | 8 | 478 | 659 | $137,193 | $39,486 |
Total Patients
2,373
Total Services
3,203
Medicare Billing
$230,784
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 90 | 160 | $50,880 | $12,108 | 23.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 87 | 87 | $21,663 | $10,789 | 49.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 98 | 98 | $13,426 | $7,524 | 56.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 29 | $6,264 | $1,622 | 25.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 13 | 13 | $572.00 | $388.57 | 67.9% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 13 | 13 | $507.00 | $283.89 | 56.0% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 12 | 16 | $400.00 | $46.65 | 11.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 213 | 399 | $126,882 | $33,259 | 26.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 114 | 114 | $28,364 | $15,325 | 54.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 130 | 130 | $17,798 | $10,103 | 56.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 112 | 159 | $34,334 | $9,624 | 28.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 13 | 13 | $5,954 | $2,222 | 37.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 56 | 57 | $2,508 | $1,747 | 69.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 13 | $5,551 | $1,683 | 30.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 11 | 11 | $1,782 | $1,455 | 81.6% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 22 | 26 | $2,652 | $1,266 | 47.7% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 56 | 57 | $2,223 | $1,199 | 53.9% |
| 90746 | Hepatitis b vaccine, adult dosage (3 dose schedule) | Office | 2022 | 13 | 15 | $1,860 | $1,042 | 56.0% |
| G0010 | Administration of hepatitis b vaccine | Office | 2022 | 13 | 15 | $750.00 | $462.26 | 61.6% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 16 | 16 | $1,344 | $454.12 | 33.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 13 | 13 | $572.00 | $401.39 | 70.2% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 32 | 42 | $1,050 | $131.82 | 12.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 190 | 376 | $114,304 | $33,642 | 29.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 113 | 166 | $34,196 | $11,674 | 34.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 79 | 79 | $18,802 | $10,817 | 57.5% |
About Dr. Joyce Endo, M.D
Dr. Joyce Endo, M.D is a Family Medicine healthcare provider based in West Linn, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760414262.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joyce Endo, M.D has received a total of $1,539 in payments from pharmaceutical and medical device companies, with $291.50 received in 2024. These payments were reported across 80 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,509).
As a Medicare-enrolled provider, Endo has provided services to 2,373 Medicare beneficiaries, totaling 3,203 services with total Medicare billing of $230,784. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location West Linn, OR
- Active Since 07/07/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1760414262
Products in Payments
- UBRELVY (Drug) $489.13
- QULIPTA (Drug) $304.12
- VRAYLAR (Drug) $95.22
- NEUROSTAR TMS THERAPY SYSTEM (Device) $67.63
- CHANTIX (Drug) $57.83
- VIAGRA (Drug) $51.75
- PROCLAIM (Device) $40.43
- AJOVY (Drug) $35.98
- Otezla (Drug) $33.83
- Respiratoriy Care Undiv (Device) $31.31
- VenaSeal (Device) $31.28
- ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION (Drug) $25.64
- SHINGRIX (Biological) $24.33
- Veozah (Drug) $20.57
- Dayvigo (Drug) $18.45
- TRINTELLIX (Drug) $18.29
- SOLIQUA 100/33 (Biological) $17.92
- Rybelsus (Drug) $17.86
- ELIQUIS (Drug) $17.81
- QELBREE (Drug) $16.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in West Linn
Dr. Ryan Scott, M.d, M.D
Family Medicine — Payments: $9,796
Family Medicine $9,796
Dr. David Farley, M.d, M.D
Family Medicine — Payments: $1,257
Family Medicine $1,257
Dr. Lawrence Tremaine, Do, DO
Family Medicine — Payments: $842.35
Family Medicine $842.35
Dr. Laurens Johansen, Md, MD
Family Medicine — Payments: $45.36
Family Medicine $45.36
Dr. Ronald Powell, D.o, D.O
Family Medicine
Family Medicine
Robert Wagner, Md, MD
Family Medicine
Family Medicine